Quick answer
What is Sermorelin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
Sermorelin is a peptide, grouped on this site under GHRH analogues, and the 12 research records kept here are 12 that do not state what kind of study it is.
The literature search returned 27 records. This site keeps 12 of them, which is 44 per cent of what came back.
What it is
This site puts it in the GHRH analogues group.
A growth hormone releasing factor analogue acting at the GHRH receptor on the anterior pituitary, upstream of growth hormone release.[1]
Stated in the title of the cited 1985 Endocrinology paper on activation of rat anterior pituitary adenylate cyclase by growth hormone releasing factor.
What kind of records
None of the records kept here state what kind of study they are.
That sentence is produced by counting, not by reading. What was counted: 12 indexed records, none of whose assigned subject headings state a study model.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 15 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.